Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238


Trend of oral and pharyngeal cancer mortality in Brazil in the period of 2002 to 2013.

Perea LME, Peres MA, Boing AF, Antunes JLF.

Rev Saude Publica. 2018 Feb 5;52:10. doi: 10.11606/S1518-8787.2018052000251. English, Portuguese.


The prevalence of human papillomavirus in pediatric tonsils: a systematic review of the literature.

Wojtera M, Paradis J, Husein M, Nichols AC, Barrett JW, Salvadori MI, Strychowsky JE.

J Otolaryngol Head Neck Surg. 2018 Jan 30;47(1):8. doi: 10.1186/s40463-018-0255-1. Review.


Genomic analysis of head and neck cancer cases from two high incidence regions.

Perdomo S, Anantharaman D, Foll M, Abedi-Ardekani B, Durand G, Reis Rosa LA, Holmila R, Le Calvez-Kelm F, Tajara EH, Wünsch-Filho V, Levi JE, Vilensky M, Polesel J, Holcatova I, Simonato L, Canova C, Lagiou P, McKay JD, Brennan P.

PLoS One. 2018 Jan 29;13(1):e0191701. doi: 10.1371/journal.pone.0191701. eCollection 2018.


Highly preserved consensus gene modules in human papilloma virus 16 positive cervical cancer and head and neck cancers.

Zhang X, Cha IH, Kim KY.

Oncotarget. 2017 Dec 7;8(69):114031-114040. doi: 10.18632/oncotarget.23116. eCollection 2017 Dec 26.


HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan.

Adilbay D, Adilbayev G, Kidirbayeva G, Shipilova V, Sadyk Z, Koyanbekova G, Sokolenko E, Klozar J.

Infect Agent Cancer. 2018 Jan 12;13:2. doi: 10.1186/s13027-018-0175-8. eCollection 2018.


Detection of HPV related oropharyngeal cancer in oral rinse specimens.

Rosenthal M, Huang B, Katabi N, Migliacci J, Bryant R, Kaplan S, Blackwell T, Patel S, Yang L, Pei Z, Tang YW, Ganly I.

Oncotarget. 2017 Nov 25;8(65):109393-109401. doi: 10.18632/oncotarget.22682. eCollection 2017 Dec 12.


Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches.

Perdomo S, Avogbe PH, Foll M, Abedi-Ardekani B, Facciolla VL, Anantharaman D, Chopard P, Calvez-Kelm FL, Vilensky M, Polesel J, Holcatova I, Simonato L, Canova C, Lagiou P, McKay JD, Brennan P.

Oncotarget. 2017 Aug 7;8(42):72621-72632. doi: 10.18632/oncotarget.20004. eCollection 2017 Sep 22.


Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.

Dahlstrom KR, Anderson KS, Field MS, Chowell D, Ning J, Li N, Wei Q, Li G, Sturgis EM.

Cancer. 2017 Dec 15;123(24):4886-4894. doi: 10.1002/cncr.30955. Epub 2017 Sep 12.


Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma.

Faraji F, Eisele DW, Fakhry C.

Laryngoscope Investig Otolaryngol. 2017 Jan 17;2(1):10-18. doi: 10.1002/lio2.37. eCollection 2017 Feb. Review.


Prophylactic immunization with human papillomavirus vaccines induces oral immunity in mice.

Ahn J, Peng S, Hung CF, Roden RBS, Best SR.

Laryngoscope. 2018 Jan;128(1):E16-E20. doi: 10.1002/lary.26772. Epub 2017 Sep 4.


GTSP1 expression in non-smoker and non-drinker patients with squamous cell carcinoma of the head and neck.

Soares PO, Maluf Cury P, Mendoza López RV, Cernea CR, Fukuyama EE, Livingstone Alves Figueiredo D, Gorgonio da Nobrega F, Curioni OA, Nunes FD, Ajub Moyses R, Bueno Garcia ML; HEAD AND NECK GENOME PROJECT–GENCAPO.

PLoS One. 2017 Aug 17;12(8):e0182600. doi: 10.1371/journal.pone.0182600. eCollection 2017.


Characteristics and outcome of laryngeal squamous cell carcinoma in young adults.

Nachalon Y, Cohen O, Alkan U, Shvero J, Popovtzer A.

Oncol Lett. 2017 Mar;13(3):1393-1397. doi: 10.3892/ol.2016.5528. Epub 2016 Dec 21.


The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection.

Laytragoon Lewin N, Lewin F, Andersson BÅ, Löfgren S, Rutqvist LE.

Med Oncol. 2017 Apr;34(4):63. doi: 10.1007/s12032-017-0912-7. Epub 2017 Mar 18. Review.


Measures of economic advantage associated with HPV-positive head and neck cancers among non-Hispanic black and white males identified through the National Cancer Database.

Peterson CE, Khosla S, Jefferson GD, Davis FG, Fitzgibbon ML, Freels S, Johnson TP, Hoskins K, Joslin CE.

Cancer Epidemiol. 2017 Jun;48:1-7. doi: 10.1016/j.canep.2017.02.011. Epub 2017 Mar 7.


Late effects of blood and marrow transplantation.

Inamoto Y, Lee SJ.

Haematologica. 2017 Apr;102(4):614-625. doi: 10.3324/haematol.2016.150250. Epub 2017 Feb 23. Review.


Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy.

Lupato V, Holzinger D, Höfler D, Menegaldo A, Giorgi Rossi P, Del Mistro A, Da Mosto MC, Pawlita M, Boscolo-Rizzo P.

PLoS One. 2017 Jan 19;12(1):e0170091. doi: 10.1371/journal.pone.0170091. eCollection 2017.


Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

Garg MK, Zhao F, Sparano JA, Palefsky J, Whittington R, Mitchell EP, Mulcahy MF, Armstrong KI, Nabbout NH, Kalnicki S, El-Rayes BF, Onitilo AA, Moriarty DJ, Fitzgerald TJ, Benson AB 3rd.

J Clin Oncol. 2017 Mar;35(7):718-726. doi: 10.1200/JCO.2016.69.1667. Epub 2017 Jan 9.


Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.

Sparano JA, Lee JY, Palefsky J, Henry DH, Wachsman W, Rajdev L, Aboulafia D, Ratner L, Fitzgerald TJ, Kachnic L, Mitsuyasu R.

J Clin Oncol. 2017 Mar;35(7):727-733. doi: 10.1200/JCO.2016.69.1642. Epub 2016 Dec 12.


Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.

Wang CJ, Sparano J, Palefsky JM.

Surg Oncol Clin N Am. 2017 Jan;26(1):17-31. doi: 10.1016/j.soc.2016.07.010. Review.

Supplemental Content

Support Center